Philip Brenner

Publications
CV
Public outreach and news

Articles

Article: GENERAL HOSPITAL PSYCHIATRY. 2024;89:23-31

Association between inflammatory joint disease and severe or treatment-resistant depression: population-based cohort and case-control studies in Sweden

Brenner P; Askling J; Hagg D; Brandt L; Stang P; Reutfors J
Journal article: NEUROSCIENCE APPLIED. 2023;2:102907

Healthcare and psychiatric drug utilization after a suicide attempt in depression: a matched cohort study from Swedish nationwide registers

Johansson V; Brenner P; Karlsson P; Borentain S; Feldman A; Reutfors J
Article: INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 2022;26(3):251-258

Health care utilisation in treatment-resistant depression: a Swedish population-based cohort study

Brenner P; Nygren A; Hagg D; Tiger M; O'Hara M; Brandt L; Reutfors J
Journal article: NEUROSCIENCE APPLIED. 2022;1:100228

Trends in hypnotic drug use in depression 2007 – 2017: a Swedish population-based study

Reutfors J; Brandt L; Cabrera P; Karlsson P; Eloranta S; Brenner P
Article: ARCHIVES OF SUICIDE RESEARCH. 2021;25(3):424-438

Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study

Reutfors J; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Brenner P
Article: THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY. 2021;11:20451253211006508-204512532110065

Excess deaths in treatment-resistant depression

Brenner P; Reutfors J; Nijs M; Andersson TM-L
Article: BMC PSYCHIATRY. 2020;20(1):232

Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study

Taipale H; Reutfors J; Tanskanen A; Brandt L; Tiihonen J; DiBernardo A; Mittendorfer-Rutz E; Brenner P
Article: ADDICTION. 2020;115(4):768-777

Substance use disorders and risk for treatment resistant depression: a population-based, nested case-control study

Brenner P; Brandt L; Li G; DiBernardo A; Boden R; Reutfors J
Article: DRUG SAFETY. 2020;43(2):135-145

A Post-Authorization Safety Study of Quetiapine as Antidepressant Treatment in Sweden: Nested Case-Control Analyses of Select Outcomes

Reutfors J; Brenner P; Brody B; Wray H; Andersen M; Brandt L
Article: PLOS ONE. 2020;15(7):e0236434

A register-based approach to identifying treatment-resistant depression-Comparison with clinical definitions

Hagg D; Brenner P; Reutfors J; Li G; DiBernardo A; Boden R; Brandt L
Article: BMC RHEUMATOLOGY. 2020;4(1):9

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

Brenner P; Citarella A; Wingard L; Sundstrom A
Article: NEUROLOGY. 2019;93(24):e2216-e2223

Disability worsening among persons with multiple sclerosis and depression A Swedish cohort study

Binzer S; McKay KA; Brenner P; Hillert J; Manouchehrinia A
Article: ADDICTION. 2019;114(7):1274-1282

Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study

Brenner P; Brandt L; Li G; DiBernardo A; Boden R; Reutfors J
Article: ANNALS OF GENERAL PSYCHIATRY. 2019;18(1):23

All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population

Li G; Fife D; Wang G; Sheehan JJ; Boden R; Brandt L; Brenner P; Reutfors J; DiBernardo A
Article: BMC PSYCHIATRY. 2018;18(1):352

Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study

DiBernardo A; Lin X; Zhang Q; Xiang J; Lu L; Jamieson C; Benson C; Lee K; Boden R; Brandt L; Brenner P; Reutfors J; Li G
Article: JOURNAL OF AFFECTIVE DISORDERS. 2018;238:674-679

Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden

Reutfors J; Andersson TM-L; Brenner P; Brandt L; DiBernardo A; Li G; Hagg D; Wingard L; Boden R
Article: PSYCHONEUROENDOCRINOLOGY. 2018;89:53-58

Depression and fatigue in multiple sclerosis: Relation to exposure to violence and cerebrospinal fluid immunomarkers

Brenner P; Granqvist M; Konigsson J; Al Nimer F; Piehl F; Jokinen J
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2016;23(8):1329-1336

Multiple sclerosis and risk of attempted and completed suicide - a cohort study

Brenner P; Burkill S; Jokinen J; Hillert J; Bahmanyar S; Montgomery S
Article: SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY. 2016;51(7):1047-1054

Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls

Brenner P; Mittendorfer-Rutz E; Jokinen J; Alexanderson K; Hillert J; Tinghog P
Article: BRAIN BEHAVIOR AND IMMUNITY. 2016;51:47-55

Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms

Aeinehband S; Brenner P; Stahl S; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Article: BMC PSYCHIATRY. 2015;15:286

Is disability pension a risk indicator for future need of psychiatric healthcare or suicidal behavior among MS patients- a nationwide register study in Sweden?

Bjorkenstam C; Tinghog P; Brenner P; Mittendorfer-Rutz E; Hillert J; Jokinen J; Alexanderson K
Journal article: NEUROLOGY. 2015;84(14_supplement)

National Swedish MS Register Based Study: the Symbol Digit Modalities Test as a predictor of work disability (P3.222)

Karrenbauer V; Brenner P; Hillert J; Tinghög P
Article: PLOS ONE. 2014;9(8):e104165

Psychiatric Diagnoses, Medication and Risk for Disability Pension in Multiple Sclerosis Patients; a Population-Based Register Study

Brenner P; Alexanderson K; Bjorkenstam C; Hillert J; Jokinen J; Mittendorfer-Rutz E; Tinghog P
Show more

All other publications

Conference publication: EUROPEAN PSYCHIATRY. 2022;65:S111

Association with severe and treatment-resistant depression among patients with inflammatory joint disease. Nationwide nested case-control study in Swedish registers.

Brenner P; Askling J; Stang P; Brandt L; Hagg D; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022;31:368-369

Prescribing patterns for glucagon-like peptide-1 receptor agonists following the introduction of semaglutide in Denmark and Norway

Rasmussen L; Andersen JH; Furu K; Karlstad O; Brenner P; Pottegard A
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021;53:S77

Health care utilization in treatment-resistant depression: a Swedish population based cohort study

Brenner P; Nygren A; Hagg D; Tiger M; O'Hara M; Brandt L; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29:70

Excess deaths associated with treatment resistance in patients with major depressive disorder

Brenner P; Brandt L; Nijs M; Reutfors J; Andersson T
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S48-S49

Risk for disability pension among antidepressant treated patients with and without treatment resistant depression: matched cohort study in Swedish registers

Taipale H; Reutfors J; Tanskanen A; Tiihonen J; Mittendorfer-Rutz E; DiBernardo A; Brandt L; Brenner P
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2019;28:99

Risk factors for suicide and suicide attempts among patients with treatment resistant depression: A population based nested case-control study

Brenner P; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27:152

Treatment resistant depression as a risk factor for substance use disorders-A national register-based cohort study

Brenner P; Hagg D; DiBernardo A; Li G; Boden R; Brandt L; Reutfors J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27:153

Substance use disorders are risk factors for treatment resistant depression

Brenner P; Brandt L; Hagg D; Li G; DiBernardo A; Boden R; Reutfors J
Thesis / dissertation: 2017

Psychiatric comorbidity in multiple sclerosis : biological and epidemiological aspects

Brenner, Philip
Review: ACTA NEUROLOGICA SCANDINAVICA. 2016;134:47-54

Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions

Brenner P; Piehl F
Conference publication: EUROPEAN PSYCHIATRY. 2015;30:616

Psychiatric Drug Consumption Among Multiple Sclerosis Patients Before and After Disability Pension; a Controlled Register Study

Brenner P; Mittendorfer-Rutz E; Jokinen J; Alexandersson K; Hillert J; Tinghog P
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:351-352

Cerebrospinal fluid kynurenines in multiple sclerosis: relation to disease course and neurocognitive symptoms

Stahl S; Aeinehband S; Brenner P; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:23-24

Multiple sclerosis and risk of completed and attempted suicide - a national cohort study

Brenner P; Burkill S; Jokinen J; Moore A; Geissbuehler Y; Hillert J; Bahmanyar S; Montgomery S
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2014;20:389

Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study

Brenner P; Jokinen J; Bjorkenstam C; Hillert J; Rutz EM; Alexandersson K; Tinghog P

Employments

Adjunct Lecturer, Department of Clinical Neuroscience, Karolinska Institutet, 2023-2024

Degrees and Education

Docent, Karlinska Institutet, 2022
Degree Of Doctor Of Philosophy, Department of Clinical Neuroscience, Karolinska Institutet, 2017

Supervisor

Silvia Segovia Chacón, Pharmacoepidemiological studies of medication use in reproductive-aged and pregnant women: focus on hypnotics and treatments for migraine, https://ki.se/en/people/silvia-segovia-chacon, 2023

Articles

All other publications

Employments

Degrees and Education

Supervisor

News from KI

Events from KI